login
login

Europe Daily Bulletin No. 12593

31 October 2020
Contents Publication in full By article 40 / 43
NEWS BRIEFS / Health
EU authorises new treatment for sickle cell anaemia

30/10/2020 (Agence Europe)Novartis will soon be able to market its treatment to prevent vaso-occlusive seizures in patients with sickle cell disease (a genetic disorder also known as sickle cell anaemia). The Swiss pharmaceutical group announced on Friday 30 October that it had received the green light from the European Commission for Adakveo, also known as crizanlizumab. The Commission thus followed the favourable opinion given in July by the Committee for Medicinal Products for...

Contents

EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
SECURITY - DEFENCE
SOCIAL AFFAIRS - EDUCATION
ECONOMY - FINANCE
BREACHES OF EU LAW
SECTORAL POLICIES
EXTERNAL ACTION
NEWS BRIEFS
CORRIGENDUM
CALENDAR
CALENDAR EXTRA